Physician profile
Sang T Pham
NPI 1679862395
$1,155.92
in general payments reported to CMS, 2019-2025
10 companies · $74.96 in 2025
The $74.96 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $79.72 · 2021: $114 · 2022: $112 · 2023: $222 · 2025: $74.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148 · Entertainment: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.38 |
| Entertainment | $148.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $339.44 | 2019-2021 | |
| Coopervision INC. | $325.21 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $148.10 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Synergeyes, INC. | $126.88 | 2019 | |
| Alcon Vision LLC | $73.42 | 2023 | Precision 1 |
| Bausch & Lomb Americas INC. | $58.74 | 2022 | |
| Sun Pharmaceutical Industries INC. | $40.58 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abb Con-Cise Optical Group LLC | $6.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sang Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.